Clinical Trials Sponsored by Sancilio and Company, Inc.
Total 262 results
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingCarcinoma, Non-Small-Cell LungUnited States, Denmark, Taiwan, China, Canada, Spain, Germany, Japan, United Kingdom, Brazil, India, Korea, Republic of, Australia, Italy, Norway, Israel, Greece, Turkey, Netherlands, Austria, Belgium, Hong Kong, Poland, Puerto Rico, Cz... and more
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, United States, Spain, Belgium, Austria, Czechia, Australia, Italy, Japan, Hungary, United Kingdom, Taiwan, Turkey, Germany, Canada, France, Israel, Poland, Croatia, Korea, Republic of, Ireland, Russian Federation, Singapore, Sw...
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingCarcinoma, Non-Small-Cell Lung | Thyroid NeoplasmsUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.No longer availableCarcinoma, Non-Small-Cell Lung | Thyroid Neoplasms
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Leukemia, Lymphoid | Leukemia, Lymphocytic, Chronic, B-CellChina
-
Eli Lilly and CompanyAbCellera Biologics Inc.No longer available
-
Loxo Oncology, Inc.Eli Lilly and CompanyAvailableBreast Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Colon Cancer | Medullary Thyroid Cancer | Papillary Thyroid Cancer | Other Solid Tumors With Evidence of Activating RET AlterationSpain, United States, Australia, France, Germany, Israel, Italy, Japan, New Zealand, Poland, Singapore, Switzerland
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Eli Lilly and CompanyLoxo Oncology, Inc.CompletedHealthyUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Loxo Oncology, Inc.Eli Lilly and CompanyCompleted
-
Loxo Oncology, Inc.CompletedHealthy VolunteersUnited States
-
Eli Lilly and CompanyAbCellera Biologics Inc.Completed
-
Eli Lilly and CompanyAurKa Pharma Inc.CompletedNeoplasms | Breast Neoplasms | Head and Neck Neoplasms | Small Cell Lung Carcinoma | Neoplasm Metastasis | Triple Negative Breast Neoplasms | Solid Tumor, AdultCanada
-
ShionogiEli Lilly and CompanyCompletedDepressive DisorderJapan
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.TerminatedSickle Cell DiseaseUnited Arab Emirates, Italy, United States, Egypt, United Kingdom, Belgium, Turkey, Brazil, Canada, Ghana, Kenya, Lebanon, Oman, Saudi Arabia
-
Daiichi Sankyo, Inc.Eli Lilly and CompanyCompletedCoronary Artery DiseaseUnited Kingdom, United States
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.CompletedAcute Coronary SyndromeUnited States, Puerto Rico
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.CompletedSickle Cell DiseaseUnited States
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.Completed
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Completed
-
Stanford UniversityEli Lilly and Company; Genentech, Inc.CompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Barbara Ann Karmanos Cancer InstituteEli Lilly and Company; Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
DICE Therapeutics, Inc., a wholly owned subsidiary...Eli Lilly and CompanyNot yet recruiting
-
DICE Therapeutics, Inc., a wholly owned subsidiary...Eli Lilly and CompanyNot yet recruiting
-
University of PittsburghEli Lilly and Company; Genentech, Inc.Completed
-
University of PittsburghEli Lilly and Company; Genentech, Inc.Completed
-
Veeda OncologyEli Lilly and Company; Sanofi; Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
University of ChicagoEli Lilly and Company; Genentech, Inc.TerminatedCarcinoma, Renal CellUnited States
-
Eli Lilly and CompanyAlgorithme Pharma Inc; CoLucid PharmaceuticalsCompletedMigraineUnited States, Canada
-
Northwestern UniversityEli Lilly and Company; Millennium Pharmaceuticals, Inc.Terminated
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedDyslipidemiaUnited States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.RecruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
University of NebraskaEli Lilly and Company; Daiichi Sankyo, Inc.Completed
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.CompletedLung CancerUnited States
-
Research Foundation for Mental Hygiene, Inc.Eli Lilly and CompanyCompletedSchizophreniaUnited States
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Daniel GriffinEli Lilly and Company; Optum, Inc.Terminated
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.Terminated
-
M.D. Anderson Cancer CenterEli Lilly and Company; Genentech, Inc.CompletedLung CancerUnited States
-
Heather WakeleeEli Lilly and Company; Genentech, Inc.CompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Boston Scientific CorporationEli Lilly and Company; Daiichi Sankyo, Inc.Completed
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.Completed
-
SCRI Development Innovations, LLCEli Lilly and Company; Genentech, Inc.CompletedBreast CancerUnited States